| Name | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
|---|---|
| Synonyms |
N-Demethyl-6-O-methylerythromycin
3&3'-N-demethyl-6-O-methylerythromycin A de(N-methyl) erythromycin A N-Demethylclarithromycin de(N-methyl)-6-O-methyl erythromycin 4'-desmethylclarithromycin N-des-methylclarithromycin Claricid Impurity 1 |
| Density | 1.18±0.1 g/cm3 (20 ºC 760 Torr) |
|---|---|
| Melting Point | 231-233 ºC |
| Molecular Formula | C37H67NO13 |
| Molecular Weight | 733.92700 |
| Exact Mass | 733.46100 |
| PSA | 191.70000 |
| LogP | 2.48840 |
| RIDADR | NONH for all modes of transport |
|---|
|
~92%
101666-68-6 |
| Literature: RIB-X-PHARMACEUTICALS, INC. Patent: WO2008/106204 A1, 2008 ; Location in patent: Page/Page column 112 ; |
|
~%
101666-68-6 |
| Literature: US2009/76253 A1, ; Page/Page column 40 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |